Mentioned On
Episode Mentions
Pharma and BioTech Daily · Jul 20, 2026
Jasper Merges with Kira for $292M | Pharma and Biotech Daily
“Zasacitinib demonstrated 75% scalp psoriasis clearance in Phase 3 trials as TYK2 inhibitor”
Jasper-Kira Pharmaceuticals MergerAutoimmune Therapeutics DevelopmentTYK2 Inhibitors for Psoriasis
View AnalysisCNBC's "Fast Money" · May 5, 2026
Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26
“Licensing partner for Protagonist's Rasvertide drug for rare blood disease; expected FDA approval Q3 2026”
AI Infrastructure Investment and Chip CompetitionCloud Computing Backlog Concentration RiskSemiconductor Market Diversification from NVIDIA
View Analysis